Bewes J M, Suchowerska N, Jackson M, Zhang M, McKenzie D R
School of Physics, University of Sydney, Sydney, NSW, Australia.
Phys Med Biol. 2008 Jul 7;53(13):3567-78. doi: 10.1088/0031-9155/53/13/012. Epub 2008 Jun 17.
Intensity-modulated radiation therapy (IMRT) achieves optimal dose conformity to the tumor through the use of spatially and temporally modulated radiation fields. In particular, average dose rate and instantaneous dose rate (pulse amplitude) are highly variable within a single IMRT fraction. In this study we isolate these variables and determine their impact on cell survival. Survival was assessed using a clonogenic assay. Two cell lines of differing radiosensitivity were examined: melanoma (MM576) and non-small cell lung cancer (NCI-H460). The survival fraction was observed to be independent of instantaneous dose rate. A statistically significant trend to increased survival was observed as the average dose rate was decreased, for a constant total dose. The results are relevant to IMRT practice, where average treatment times can be significantly extended to allow for movement of the multi-leaf collimator (MLC). Our in vitro study adds to the pool of theoretical evidence for the consequences of protracted treatments. We find that extended delivery times can substantially increase the cell survival. This also suggests that regional variation in the dose-rate history across a tumor, which is inherent to IMRT, will affect radiation dose efficacy.
调强放射治疗(IMRT)通过使用空间和时间调制的辐射野实现对肿瘤的最佳剂量适形。特别是,在单次IMRT分次治疗中,平均剂量率和瞬时剂量率(脉冲幅度)变化很大。在本研究中,我们分离出这些变量并确定它们对细胞存活的影响。使用克隆形成试验评估细胞存活情况。研究了两种放射敏感性不同的细胞系:黑色素瘤(MM576)和非小细胞肺癌(NCI-H460)。观察到存活分数与瞬时剂量率无关。对于恒定的总剂量,随着平均剂量率降低,观察到存活增加的统计学显著趋势。这些结果与IMRT实践相关,在IMRT中,平均治疗时间可以显著延长以允许多叶准直器(MLC)移动。我们的体外研究为延长治疗的后果增添了理论证据。我们发现延长的给药时间可显著增加细胞存活。这也表明IMRT固有的肿瘤内剂量率历史的区域差异将影响放射剂量疗效。